Danish biotech flat on Neuer Markt and Copenhagen debut

Share trading in Genmab, the Danish biotech company, experienced a flat first day on Frankfurt's Neuer Markt and even its home market the Copenhagen Stock Exchange.

Genmab, which on Wednesday launched a dual listing in Denmark and Germany, saw its shares trading down on both markets.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump